# "Stop Early Age-related Macular Degeneration (AMD) From Vision Loss Eternally" Study

> **NCT02960828** · NA · UNKNOWN · sponsor: **Seoul National University Bundang Hospital** · enrollment: 21 (estimated)

## Conditions studied

- Age-Related Macular Degeneration
- Retinal Drusen

## Interventions

- **PROCEDURE:** Subthreshold Laser Photocoagulation
- **DRUG:** intravitreal Anti-VEGF injection
- **DEVICE:** Subthreshold Laser

## Key facts

- **NCT ID:** NCT02960828
- **Lead sponsor:** Seoul National University Bundang Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-01
- **Primary completion:** 2020-05
- **Final completion:** 2020-12
- **Target enrollment:** 21 (ESTIMATED)
- **Last updated:** 2019-09-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02960828

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02960828, ""Stop Early Age-related Macular Degeneration (AMD) From Vision Loss Eternally" Study". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT02960828. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*